Scarica l'app Stockscreener
15.90
7.15%
0.995
Dopo l'orario di chiusura:
15.90
Precedente Chiudi:
$14.90
Aprire:
$14.51
Volume 24 ore:
96,946
Relative Volume:
0.59
Capitalizzazione di mercato:
$665.16M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-0.75%
1M Prestazione:
+42.84%
6M Prestazione:
+121.50%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$14.51
$16.17
Intervallo di 1 settimana:
$13.99
$16.38
Portata 52W:
$5.83
$26.25
Zenas Biopharma Inc Stock (ZBIO) Company Profile
Nome
Zenas Biopharma Inc
Settore
Industria
Telefono
857-271-2954
Indirizzo
852 WINTER STREET, SUITE 250, WALTHAM
Confronta ZBIO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ZBIO
Zenas Biopharma Inc
|
15.90 | 612.03M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 93.98B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 59.67B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.53B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 40.50B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.26B | 3.81B | -644.79M | -669.77M | -6.24 |
Zenas Biopharma Inc Stock (ZBIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-20 | Iniziato | Wedbush | Outperform |
| 2025-02-04 | Iniziato | Wolfe Research | Outperform |
| 2024-12-16 | Iniziato | H.C. Wainwright | Buy |
| 2024-11-05 | Iniziato | Rodman & Renshaw | Buy |
| 2024-10-08 | Iniziato | Citigroup | Buy |
| 2024-10-08 | Iniziato | Guggenheim | Buy |
| 2024-10-08 | Iniziato | Jefferies | Buy |
| 2024-10-08 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Zenas Biopharma Inc Borsa (ZBIO) Ultime notizie
Zenas BioPharma Reports Second Quarter 2025 Financial Results and Provides Corporate Updates - GlobeNewswire
Zenas BioPharma Advances 3 Major Clinical Trials with $274M Cash Runway Through 2026 - Stock Titan
Zenas BioPharma Inc.’s Price Action Aligns with Quant SignalsConsistent Gain Investment Strategies Emerge - beatles.ru
How many analysts rate Zenas BioPharma Inc. as a “Buy”Get daily expert analysis on top stocks - Jammu Links News
Is Zenas BioPharma Inc. a growth stock or a value stockTriple-digit wealth increases - Jammu Links News
Zenas BioPharma Inc. Stock Analysis and ForecastInvest confidently with data-driven strategies - Jammu Links News
When is Zenas BioPharma Inc. stock expected to show significant growthUnlock exclusive trading strategies for gains - Jammu Links News
Is Zenas BioPharma Inc. a good long term investmentMaximize gains with professional stock picks - Jammu Links News
What are Zenas BioPharma Inc. company’s key revenue driversFree Daily Trading Room Entry - Jammu Links News
What are the latest earnings results for Zenas BioPharma Inc.Tremendous growth potential - Jammu Links News
Does Zenas BioPharma Inc. stock perform well during market downturnsSuperior trading gains - Jammu Links News
Is Zenas BioPharma Inc. stock overvalued or undervaluedExplosive earnings growth - Jammu Links News
Is it the right time to buy Zenas BioPharma Inc. stockMaximize portfolio value with smart investment plans - Jammu Links News
How strong is Zenas BioPharma Inc. company’s balance sheetInvest in stocks with strong fundamentals - Jammu Links News
What is the risk reward ratio of investing in Zenas BioPharma Inc. stockOutstanding capital returns - Jammu Links News
3 Highly Shorted Stocks That Could Be The Next Wall Street Sensations - Barchart.com
What are the technical indicators suggesting about Zenas BioPharma Inc.Daily Trading Guidance With Low Risk - Jammu Links News
Why is Zenas BioPharma Inc. stock attracting strong analyst attentionEntry Signal Planner To Watch Now - Jammu Links News
What is Zenas BioPharma Inc. company’s growth strategyPost Market Target Finder For Every Investor - jammulinksnews.com
Zenas BioPharma Inc. Shows Support at Fibonacci LevelVolume Based Entry Signal Strategy - beatles.ru
What makes Zenas BioPharma Inc. stock price move sharplyConsistent Gain Investment Strategies Emerge - metal.it
Zenas BioPharma Inc. Breaks Losing Streak — Is the Trend ReversingTrade Setups With AI Powered Filters Published - metal.it
What does ZBIO's flat EPS in 2024 suggest for short-term traders? - AInvest
Can Traders Expect Breakout From Zenas BioPharma Inc. This WeekTriple Digit Return Stock Predictions Released - metal.it
Zenas BioPharma to Present at the Jefferies Global Healthcare Conference - The Globe and Mail
Zenas Biopharma: A Risky Buy On Upcoming Data Readouts In IgG4, MS (NASDAQ:ZBIO) - Seeking Alpha
How does Zenas BioPharma Inc. generate profit in a changing economyUnlock powerful market trend analysis - Jammu Links News
Warm Autoimmune Hemolytic Anemia Market Expands Amid Increased - openPR.com
Key External Factors That Drive Zenas BioPharma Inc. Stock Price MovementsRisk Limited High Gain Trades - metal.it
Zenas BioPharma Inc. Company’s Quarterly Earnings Growth: What the Numbers SayInstant Stock Updates - metal.it
Competitive Positioning of Zenas BioPharma Inc.: Is It Leading or LaggingFree Stock Selection - metal.it
How volatile is Zenas BioPharma Inc. stock compared to the marketRecord-setting profit potential - Jammu Links News
Zenas Biopharma Inc Azioni (ZBIO) Dati Finanziari
Non sono disponibili dati finanziari per Zenas Biopharma Inc (ZBIO). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Zenas Biopharma Inc Azioni (ZBIO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Xiao Ting | Director |
Feb 07 '25 |
Buy |
7.76 |
10,000 |
77,600 |
47,000 |
| MOULDER LEON O JR | Chief Executive Officer |
Dec 04 '24 |
Buy |
9.98 |
45,000 |
449,100 |
241,155 |
| MOULDER LEON O JR | Chief Executive Officer |
Dec 03 '24 |
Buy |
10.76 |
25,000 |
269,000 |
196,155 |
| MOULDER LEON O JR | Chief Executive Officer |
Nov 18 '24 |
Buy |
15.00 |
7,500 |
112,500 |
168,655 |
| MOULDER LEON O JR | Chief Executive Officer |
Nov 19 '24 |
Buy |
14.57 |
2,500 |
36,425 |
171,155 |
| MOULDER LEON O JR | Chief Executive Officer |
Sep 18 '24 |
Buy |
17.91 |
10,000 |
179,100 |
1,662,039 |
| MOULDER LEON O JR | Chief Executive Officer |
Sep 20 '24 |
Buy |
18.45 |
5,000 |
92,270 |
1,672,039 |
| MOULDER LEON O JR | Chief Executive Officer |
Sep 19 '24 |
Buy |
17.89 |
5,000 |
89,450 |
1,667,039 |
| Enavate Sciences GP, LLC | 10% Owner |
Sep 16 '24 |
Buy |
17.00 |
882,353 |
15,000,001 |
3,761,359 |
| Lu Hongbo | Director |
Sep 13 '24 |
Buy |
17.00 |
58,823 |
999,991 |
58,823 |
0.97%
2.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):